Inflammation in coronary artery disease: potential role for immunomodulatory therapy (Q36314881)

13 August 2017

1 reference

title

Inflammation in coronary artery disease: potential role for immunomodulatory therapy (English)

1 reference

13 August 2017

0 references

coronary artery disease

1 reference

1

Pål Aukrust

0 references

Jan Kristian Damås

series ordinal

6

object named as

Jan Kristian Damås

0 references

Lars Gullestad

series ordinal

4

object named as

Lars Gullestad

1 reference

13 August 2017

5

Bente Halvorsen

1 reference

13 August 2017

2

Arne Yndestad

1 reference

13 August 2017

3

Torgun Waehre

1 reference

13 August 2017

publication date

1 November 2005

1 reference

Expert Review of Cardiovascular Therapy

13 August 2017

published in

1 reference

13 August 2017

volume

3

1 reference

13 August 2017

issue

6

1 reference

13 August 2017

page(s)

1111-1124

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.6.1111

13 August 2017

1 reference

Current concepts of the pathogenesis of the acute coronary syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.6.1111

Inflammation, atherosclerosis, and coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.6.1111

Chemokines, leukocytes, and atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.6.1111

Chemokine receptors in vascular smooth muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.6.1111

Platelets and chemokines in atherosclerosis: partners in crime

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.6.1111

Decreased lesion formation in CCR2-/- mice reveals a role for chemokines in the initiation of atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.6.1111

A leukocyte homologue of the IL-8 receptor CXCR-2 mediates the accumulation of macrophages in atherosclerotic lesions of LDL receptor-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.6.1111

Differential expression of three T lymphocyte-activating CXC chemokines by human atheroma-associated cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.6.1111

Decreased atherosclerotic lesion formation in CX3CR1/apolipoprotein E double knockout mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.6.1111

Decreased atherosclerosis in CX3CR1-/- mice reveals a role for fractalkine in atherogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.6.1111

Tissue factor is induced by monocyte chemoattractant protein-1 in human aortic smooth muscle and THP-1 cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.6.1111

Interaction between chemokines and oxidative stress: possible pathogenic role in acute coronary syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.6.1111

CD40 signaling and plaque instability

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.6.1111

The CD40/CD154 receptor/ligand dyad

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.6.1111

Functional CD40 ligand is expressed on human vascular endothelial cells, smooth muscle cells, and macrophages: implications for CD40-CD40 ligand signaling in atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.6.1111

Expression of stromelysin-3 in atherosclerotic lesions: regulation via CD40-CD40 ligand signaling in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.6.1111

Requirement for CD154 in the progression of atherosclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.6.1111

Both early and delayed anti-CD40L antibody treatment induces a stable plaque phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.6.1111

CD40 ligand on activated platelets triggers an inflammatory reaction of endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.6.1111

Effect of atorvastatin on risk of recurrent cardiovascular events after an acute coronary syndrome associated with high soluble CD40 ligand in the Myocardial Ischemia Reduction with Aggressive Cholesterol Lowering (MIRACL) Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.6.1111

Lesion development and response to immunization reveal a complex role for CD4 in atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.6.1111

Hypercholesterolemia is associated with a T helper (Th) 1/Th2 switch of the autoimmune response in atherosclerotic apo E-knockout mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.6.1111

Inhibition of transforming growth factor-beta signaling accelerates atherosclerosis and induces an unstable plaque phenotype in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.6.1111

Expression of interleukin (IL)-18 and functional IL-18 receptor on human vascular endothelial cells, smooth muscle cells, and macrophages: implications for atherogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.6.1111

IFN-gamma potentiates atherosclerosis in ApoE knock-out mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.6.1111

IFN-gamma deficiency exerts gender-specific effects on atherogenesis in apolipoprotein E-/- mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.6.1111

Exogenous interferon-gamma enhances atherosclerosis in apolipoprotein E-/- mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.6.1111

Interleukin-18 enhances atherosclerosis in apolipoprotein E(-/-) mice through release of interferon-gamma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.6.1111

Innate and adaptive immunity in the pathogenesis of atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.6.1111

Mechanisms of suppression by suppressor T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.6.1111

Evidence for antigen-driven T-cell response in unstable angina

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.6.1111

Expression of interleukin-15 in mouse and human atherosclerotic lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.6.1111

Interleukin-15 expression in atherosclerotic plaques: an alternative pathway for T-cell activation in atherosclerosis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.6.1111

Interleukin-7-mediated inflammation in unstable angina: possible role of chemokines and platelets

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.6.1111

Infection with Chlamydia pneumoniae accelerates the development of atherosclerosis and treatment with azithromycin prevents it in a rabbit model

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.6.1111

Role of heat shock proteins in atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.6.1111

Chlamydial and human heat shock protein 60s activate human vascular endothelium, smooth muscle cells, and macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.6.1111

Chlamydia pneumoniae and chlamydial heat shock protein 60 stimulate proliferation of human vascular smooth muscle cells via toll-like receptor 4 and p44/p42 mitogen-activated protein kinase activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.6.1111

Inflammatory response after open heart surgery: release of heat-shock protein 70 and signaling through toll-like receptor-4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.6.1111

Toll-like receptor-4 is expressed by macrophages in murine and human lipid-rich atherosclerotic plaques and upregulated by oxidized LDL.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.6.1111

Minimally modified LDL binds to CD14, induces macrophage spreading via TLR4/MD-2, and inhibits phagocytosis of apoptotic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.6.1111

Oxidative stress as a regulator of gene expression in the vasculature

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.6.1111

Reactive oxygen species, metalloproteinases, and plaque stability

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.6.1111

Atherogenesis in perspective: hypercholesterolemia and inflammation as partners in crime

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.6.1111

Oxidized phospholipids, Lp(a) lipoprotein, and coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.6.1111

T lymphocytes from human atherosclerotic plaques recognize oxidized low density lipoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.6.1111

Apoptosis in atherosclerosis: focus on oxidized lipids and inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.6.1111

Temporal increases in plasma markers of oxidized low-density lipoprotein strongly reflect the presence of acute coronary syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.6.1111

Elevated levels of oxidized low density lipoprotein show a positive relationship with the severity of acute coronary syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.6.1111

Stabilization of atherosclerotic plaques: new mechanisms and clinical targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.6.1111

Aspirin and other cyclooxygenase inhibitors: new therapeutic insights

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.6.1111

Statin therapy: beyond cholesterol lowering and antiinflammatory effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.6.1111

Vascular effects of HMG CoA-reductase inhibitors (statins) unrelated to cholesterol lowering: new concepts for cardiovascular disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.6.1111

Antiinflammatory and antiarteriosclerotic actions of HMG-CoA reductase inhibitors in a rat model of chronic inhibition of nitric oxide synthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.6.1111

Statins selectively inhibit leukocyte function antigen-1 by binding to a novel regulatory integrin site

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.6.1111

Inflammation, immunity, and HMG-CoA reductase inhibitors: statins as antiinflammatory agents?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.6.1111

Increased expression of interleukin-1 in coronary artery disease with downregulatory effects of HMG-CoA reductase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.6.1111

Raised serum levels of soluble CD40 ligand in patients with familial hypercholesterolemia: downregulatory effect of statin therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.6.1111

Measurement of C-reactive protein for the targeting of statin therapy in the primary prevention of acute coronary events

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.6.1111

Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.6.1111

Angiotensin II and atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.6.1111

Angiotensin, fibrinolysis, and vascular homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.6.1111

Concurrent treatment with renin-angiotensin system blockers and acetylsalicylic acid reduces nuclear factor kappaB activation and C-reactive protein expression in human carotid artery plaques

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.6.1111

PPAR activators as antiinflammatory mediators in human T lymphocytes: implications for atherosclerosis and transplantation-associated arteriosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.6.1111

Gemfibrozil Reduces Plasma C-Reactive Protein Levels in Abdominally Obese Men With the Atherogenic Dyslipidemia of the Metabolic Syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.6.1111

Gemfibrozil for the secondary prevention of coronary heart disease in men with low levels of high-density lipoprotein cholesterol. Veterans Affairs High-Density Lipoprotein Cholesterol Intervention Trial Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.6.1111

PPARgamma and atherosclerosis: effects on cell growth and movement

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.6.1111

Peroxisome proliferator-activated receptor gamma ligands inhibit development of atherosclerosis in LDL receptor-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.6.1111

Effect of rosiglitazone treatment on nontraditional markers of cardiovascular disease in patients with type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.6.1111

Polyclonal antibody directed against human RANTES ameliorates disease in the Lewis rat adjuvant-induced arthritis model

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.6.1111

An antagonist of monocyte chemoattractant protein 1 (MCP-1) inhibits arthritis in the MRL-lpr mouse model

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.6.1111

Antagonism of RANTES receptors reduces atherosclerotic plaque formation in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.6.1111

Genetic co-inactivation of macrophage- and T-tropic HIV-1 chemokine coreceptors CCR-5 and CXCR-4 by intrakines

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.6.1111

New anti-monocyte chemoattractant protein-1 gene therapy attenuates atherosclerosis in apolipoprotein E-knockout mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.6.1111

Overexpression of interleukin-10 by activated T lymphocytes inhibits atherosclerosis in LDL receptor-deficient Mice by altering lymphocyte and macrophage phenotypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.6.1111

Cross-regulatory roles of interleukin (IL)-12 and IL-10 in atherosclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.6.1111

Interleukin-10 enhances the oxidized LDL-induced foam cell formation of macrophages by antiapoptotic mechanisms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.6.1111

Serum levels of the antiinflammatory cytokine interleukin-10 are decreased in patients with unstable angina

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.6.1111

Immunoglobulin treatment reduces atherosclerosis in apo E knockout mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.6.1111

Monoclonal autoantibodies specific for oxidized phospholipids or oxidized phospholipid-protein adducts inhibit macrophage uptake of oxidized low-density lipoproteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.6.1111

Pneumococcal vaccination decreases atherosclerotic lesion formation: molecular mimicry between Streptococcus pneumoniae and oxidized LDL.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.6.1111

Vaccination against atherosclerosis: science or fiction?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.6.1111

Immunization of low density lipoprotein (LDL) receptor-deficient rabbits with homologous malondialdehyde-modified LDL reduces atherogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.6.1111

Mucosal administration of heat shock protein-65 decreases atherosclerosis and inflammation in aortic arch of low-density lipoprotein receptor-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.6.1111

CDC/AHA Workshop on Markers of Inflammation and Cardiovascular Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.6.1111

Expression of Interleukin-18 in Human Atherosclerotic Plaques and Relation to Plaque Instability

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.6.1111

Molecular Fingerprint of Interferon-γ Signaling in Unstable Angina

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.6.1111

10.1586/14779072.3.6.1111

21 January 2018

Identifiers

DOI

1 reference

13 August 2017

1 reference